title: Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease.
abstract: T lymphocytes play a pivotal role in graft-versus-host disease (GVHD) and largely contribute to the graft-versus-leukemia (GVL) effect. Most mature T lymphocytes specifically recognize antigens through the alpha/beta T-cell receptor (TCR). Each alpha/beta TCR chain includes a constant region and a variable region, the latter being encoded by V-J alpha or V-D-J beta rearranged gene segments. To better characterize T cells involved in GVHD, V alpha and V beta gene segment usage was analyzed, after cDNA amplification, in peripheral blood mononuclear cells (PBMC) and skin samples from three patients with grade II cutaneous GVHD. At time of GVHD diagnosis (days 11, 22, and 25), when first signs of engraftment were detectable, virtually all V alpha and V beta subfamilies were represented in PBMC RNAs of the three recipients. These results suggest that diversified TCR gene segment expression is observed early after allogenic bone marrow transplantation (alloBMT). Lymphocytes infiltrating GVHD skin also expressed a large series of V alpha and V beta subfamily specificities. However, analysis of the V alpha and V beta amplified products showed substantial differences between PBMC and the skin lymphocyte RNAs. These observations indicate that a large variety of T lymphocytes are present at the disease site, while some of them may be specifically amplified or decreased in response to minor histocompatibility antigens (miHA). Further characterization of the latter T-cell subpopulations should lead to a better understanding of human in vivo responses directed at miHA.
authors.affiliation: Hemato-Immunology Unit, INSERM U333, Institut Gustave Roussy, Villejuif, France.
authors.forename: P Y
authors.initials: PY
authors.lastname: Dietrich
authors.forename: A
authors.initials: A
authors.lastname: Caignard
authors.forename: A
authors.initials: A
authors.lastname: Diu
authors.forename: C
authors.initials: C
authors.lastname: Genevee
authors.forename: J L
authors.initials: JL
authors.lastname: Pico
authors.forename: M
authors.initials: M
authors.lastname: Henry-Amar
authors.forename: J
authors.initials: J
authors.lastname: Bosq
authors.forename: E
authors.initials: E
authors.lastname: Angevin
authors.forename: F
authors.initials: F
authors.lastname: Triebel
authors.forename: T
authors.initials: T
authors.lastname: Hercend
mesh_terms: D000208:Acute Disease; D000328:Adult; D015139:Blotting, Southern; D016026:Bone Marrow Transplantation / Q000276:immunology*; D005260:Female; D015329:Gene Rearrangement, T-Lymphocyte; D014644:Genetic Variation; D006086:Graft vs Host Disease / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000628:therapy; D007951:Leukemia, Myeloid / Q000235:genetics / Q000628:therapy; D008297:Male; D016133:Polymerase Chain Reaction; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D012867:Skin / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous
chemical_list: D011948:Receptors, Antigen, T-Cell